NCT06169228

Brief Summary

Sleep is an important factor that influences long-term quality of life with known health consequences. Obstructive sleep apnea, the most prevalent disease that disturbs sleep, is considered a public health problem. Treatment with continuous positive airway pressure is cost effective and reverses the clinical consequences but there is a percentage of patients who do not tolerate it or leave it without treatment and with potential future health complications. Mandibular advancement device can be a valid and well tolerated alternative, it is known that it reduces apnea-hypopnea index, but its effect on the improvement of sleep quality is evaluated by polysomnography that interferes with the quality of sleep. There is an ambulatory monitoring device for sleep quality and circadian rhythms, which can register prolonged periods of time, under natural conditions and at a lower cost than a polysomnography. This pilot project assesses whether mandibular advancement device is an effective and well tolerated alternative in the treatment of obstructive sleep apnea to improve the quality of life and sleep in the medium and long term.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2023

Completed
11 months until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 13, 2023

Status Verified

December 1, 2023

Enrollment Period

1.7 years

First QC Date

January 30, 2023

Last Update Submit

December 5, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • mandibular advancement device on sleep quality

    Tolerability and efficacy of treatment with a mandibular advancement device (MAD) on sleep quality in patients with Obstructive Sleep Apnea (OSA) measured by the ambulatory circadian monitoring device.

    3 years

  • ambulatory circadian monitoring device

    To evaluate improvement in sleep quality with mandibular advancement devices measured by fragmentation and stability of sleep by the circadian monitoring sensor.

    3 years

  • home sleep apnea test

    To evaluate the number of residual apneic breaths measured by home home sleep apnea test

    3 years

Secondary Outcomes (4)

  • Obstructive sleep apnea severity

    3 years

  • questionnaire SF-12

    3 years

  • questionnaire EuroQoL

    3 years

  • questionnaire iPAQ

    3 years

Interventions

The multidisciplinary sleep unit assessment and follow-up protocol will be followed for this group of patients based on the Spanish Clinical Practice Guideline of the Spanish Sleep Society (SES) on the use of mandibular advancement devices in the treatment of patients with obstructive sleep apnea

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who come to the Multidisciplinary sleep unit of the Fundación Jiménez Díaz with suspicion of Obstructive sleep apnea and who present an Apnea Hypopnea Index greater than five

You may qualify if:

  • Diagnosis of Obstructive Sleep Apnea Syndrome
  • opt for mandibular advancement device as 1st treatment alternative
  • opt for mandibular advancement device due to intolerance to continuous positive airway pressure

You may not qualify if:

  • Patient with orthodontics, malocclusion and periodontal or temporomandibular joint disease who, after assessment by dentistry contraindicates it.
  • Central Sleep apnea (more than 50% of central events in the baseline polygraph).
  • Under 18 years old.
  • Pregnancy
  • Comorbidities that can potentially alter sleep architecture.
  • Psychophysical inability to complete questionnaires.
  • Not obtaining informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Fernanda Troncoso Acevedo

Madrid, 28004, Spain

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Mandibular Advancement

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Oral Surgical ProceduresSurgical Procedures, OperativeDentistryOrthodontics

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigador principal

Study Record Dates

First Submitted

January 30, 2023

First Posted

December 13, 2023

Study Start

January 1, 2021

Primary Completion

September 30, 2022

Study Completion

December 31, 2024

Last Updated

December 13, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations